Skip to content
i2E
  • Programs
    • For Startups
      • E3
      • Bridge2
      • OCN
    • For Students
      • Entrepreneur’s Cup
    • For Corporations
    • For Investors
  • Client Portfolio
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Events
  • Contact
  • Media
  • Programs
    • For Startups
      • E3
      • Bridge2
      • OCN
    • For Students
      • Entrepreneur’s Cup
    • For Corporations
    • For Investors
  • Client Portfolio
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Events
  • Contact
  • Media
Search

OKBio Scholarship Provides Partnering Experience

Get in Touch

My company, EpimedX, was fortunate to be awarded the OKBio-sponsored BIO scholarship, allowing me to attend the convention for the first time. EpimedX Co-Founder and COO, Dr. Robert Floyd, has attended the convention for several years and understands the great opportunity that this large international meeting holds. Together, we prepared in advance to meet with as many potential partners as possible during our time in San Diego.

The primary vision of EpimedX is to produce a novel therapeutic for Sickle Cell Disease. In the United States, approximately 100,000 patients suffer with this disease. Millions suffer worldwide and billions of dollars are lost from the economy as a result of lost productivity and healthcare costs. EpimedX is developing a small molecule, EdX-17, that enhances specific genes and signaling pathways in order to shift the hemoglobin profile in red blood cells – and thereby prevent sickling. This treatment has the potential to prevent and reverse symptoms of Sickle Cell Disease.

Commercialization of EdX-17 has the potential to provide significantly better treatment, alleviation of symptoms, improved quality of life/longevity, and greatly reduced treatment costs. Drug development costs are high, however, and EpimedX must seek partnership with industry giants to achieve this goal.

Dr. Floyd and I were fortunate to have 4 global pharmaceutical companies show interest in our technology. We met with representatives from Merck Serono, Amgen, Roche and Sanofi/Genzyme. The overwhelming response was positive – yet all of the representatives suggested that we are currently too early on the commercialization path to partner. We expected this response, but we consider this year at the BIO convention as a step in the right direction – we believe that an early introduction to the technology will potentially lead to negotiations in the future as we demonstrate success and achieve milestones.

In addition to partnering meetings I was able to attend seminars and panel discussions on orphan drug development and financing, patient focused drug development, pediatric clinical trials, and tips for working with the FDA. These talks were relevant to our drug development plan and therefore extremely beneficial.

Lastly, working at the OKBio booth allowed for making connections with new potential partners and collaborators from other states and countries, as well as solidify relationships with others working on projects in our state.

Overall, the trip was extremely beneficial and I hope to have the opportunity to go again next year.

Carol D. Curtis, PhD
Associate Director of R&D
EpimedX, LLC

More News

Loading...
Blog, Featured, News
06.25.25

i2E Showcases Startup Innovation at Bridge2 Cohort 3 Demo Day

Read more
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
04.25.25

Oklahoma Collegiate Entrepreneurs Take Home Over $167K at Entrepreneur’s Cup

Read more
Blog, Featured, News
12.16.24

MidAmerica and i2E Announce Award Winners

Read more
Blog, Featured, News
11.21.24

i2E & Plains Ventures Surpasses $100M Milestone in Total Investments

Read more
Blog
09.30.24

i2E Receives 2024 Excellence in Economic Development Award from IEDC

Read more
Blog
06.18.24

Bridge2 Demo Day Returns, Highlighting Promising Oklahoma Startups

Read more
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
05.13.24

Student Entrepreneurs Triumph at 20th Anniversary Entrepreneur’s Cup, Winning $158,000 in Prizes

Read more
Default Featured Image
Blog, Entrepreneur's Cup News
04.24.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – Jessica Kinsey

Read more
Default Featured Image
Blog, Entrepreneur's Cup News
04.23.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – Nathan Fountain

Read more
Default Featured Image
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
04.23.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – Srijita Ghosh

Read more
Default Featured Image
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
04.18.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – MaxQ

Read more
Blog, i2E
01.30.24

i2E Celebrates Success of Inaugural Bridge2 Demo Day

Read more
i2E

Oklahoma City Office

201 Robert S Kerr Ave, Suite 600
Oklahoma City, OK 73102
+1 (405) 235.2305

Tulsa Office

12 N. Cheyenne Ave, Suite 112
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources
  • Funding
  • Venture Advisory

© 2025 i2E Privacy Policy

Follow us:

Linkedin Twitter Facebook Instagram Youtube

Programs

  • For Startups
    • E3
    • Bridge2
    • OCN
  • For Students
    • Entrepreneur’s Cup
  • For Corporations
  • For Investors
  • For Startups
    • E3
    • Bridge2
    • OCN
  • For Students
    • Entrepreneur’s Cup
  • For Corporations
  • For Investors
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Events
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E